The goal of this chapter is to present the WISDOM initiative, which is one of the main accomplishments in the use of grids for biomedical sciences achieved on grid infrastructures in Europe. Researchers in life sciences are among the most active scientifi c communities on the EGEE infrastructure. As a consequence, the biomedical virtual organization stands fourth in terms of resources consumed in 2007, with an average of 7000 jobs submitted every day to the grid and more than 4 million hours of CPU consumed in the last 12 months. Only three experiments on the CERN Large Hadron Collider have used more resources. Compared to particle physics, the use of resources is much less centralized as about 40 different scientifi c applications are now currently deployed on EGEE. Each of them requires an amount of CPU which ranges from a few to a few hundred CPU years. Thanks to the 20,000 processors available to the users of the biomedical virtual organization, crunching factors in the hundreds are witnessed routinely. Such performances were already achieved on supercomputers but at the cost of reservation and long delays in the access to resources. On the contrary, grid infrastructures are constantly open to the user communities. Such changes in the scale of the computing resources made continuously available to the researchers in biomedical sciences open opportunities for exploring new fi elds or changing the approach to existing challenges. In this chapter, we would like to show the potential impact of grids in the fi eld of drug discovery through the example of the WISDOM initiative.
WISDOM, a grid enabled drug discovery initiative against malaria / V., Breton; D., Kim; Rastelli, Giulio. - STAMPA. - (2009), pp. 359-387.
|Data di pubblicazione:||2009|
|Titolo:||WISDOM, a grid enabled drug discovery initiative against malaria|
|Autore/i:||V., Breton; D., Kim; Rastelli, Giulio|
|Codice identificativo Scopus:||2-s2.0-85056380706|
|Titolo del libro:||Grid Computing: infrastructure, Service, and Applications|
|Editore:||CRC press, a Taylor & Francis company|
|Nazione editore:||REGNO UNITO DI GRAN BRETAGNA|
|Citazione:||WISDOM, a grid enabled drug discovery initiative against malaria / V., Breton; D., Kim; Rastelli, Giulio. - STAMPA. - (2009), pp. 359-387.|
I documenti presenti in Iris Unimore sono rilasciati con licenza Creative Commons Attribuzione - Non commerciale - Non opere derivate 3.0 Italia, salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris